37th cycle (2021)

This page contains information about the admission to Oncology, Hematology and Pathology PhD program for a.y. 2021/2022


General information about the Call for applications and candidate selection is available at the following website:


 The 37th cycle is active starting from 1st November 2021

MSCA PhD positions


"VAGABOND - Validation of Actionable Genomic Aberrations in a paediatric Oncology Network for Doctorate students" aims to create a multidisciplinary and multi-sectoral programme to validate new therapeutic interventions in paediatric cancer. The project is funded by the European Commission under the Horizon 2020 programme (Marie Sklodowska-Curie Actions Innovative Training networking) and offers 15 fully funded PhD positions.

The consortium is coordinated by the Princess Maxima center for Pediatric Oncology and consists of 12 academic partners including Istituto Ortopedico Rizzoli (P.I. Prof. K. Scotlandi) and 6 non-academic partners from 8 different European Countries.

The research projects are focused on the identification/validation of genetic, epigenetic, and immunological targets, that are relevant for the pathogenesis of pediatric tumors. Functional studies will be set up on experimental models, which are representative of the clinical situation through cutting-edge technologies. PhD students will have the opportunity to perform secondments at the participating Centers.

PhD vacancies and characteristics of the project can be found at the following link: https://vagabondnetwork.com/career/
The closing date for the PhD positions is December 1st.
For more information you can visit the web site: https://vagabondnetwork.com/